Technical Analysis for GDR - Genedrive Plc

Grade Last Price % Change Price Change
B 29.50 22.92% 5.50
GDR closed up 22.92 percent on Friday, January 27, 2023, on 8.08 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Very Strong Up Up Up

Date Alert Name Type % Chg
Expansion Breakout Bullish Swing Setup 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Parabolic Rise Strength 0.00%
Upper Bollinger Band Walk Strength 0.00%
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Gapped Up Strength 0.00%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Genedrive Plc Description

Genedrive Plc, formerly Epistem Holdings Plc, is a holding company engaged in molecular diagnostics business. The Company operates through segments, including Preclinical Research Services, Pharmacogenomics Services and Diagnostics. Its geographical segments include the United Kingdom, Europe, the United States of America and Asia. Its Preclinical Research Services segment provides pre-clinical testing services. Its Pharmacogenomic Services segment specializes in molecular measures of biological effect. Its Diagnostics segment is commercializing the Genedrive molecular testing platform. Its Preclinical Research Services activities relate to the testing of drugs for drug development companies. The Preclinical Research Services division has developed a range of models across therapeutic pathways, including oncology, gastrointestinal disease, skin care and wound healing. The Pharmacogenomics Service offers multi system transcriptional profiling and laser capture microscopy.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Gas Biotechnology Life Sciences Disease Clinic Testing Drugs Oncology Skin Laser Skin Care Drug Development E Testing Health Sciences Omics Molecular Clinical Research Medical Genetics Microscopy Pharmacology Profiling Clinical Research Services Genomics Genomics Services Molecular Diagnostics Pre Clinical Development

Is GDR a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Recent News

Indicators

Indicator Value
52 Week High 41.89
52 Week Low 8.0
Average Volume 1,377,533
200-Day Moving Average 16.46
50-Day Moving Average 11.44
20-Day Moving Average 14.28
10-Day Moving Average 17.47
Average True Range 2.32
RSI 92.27
ADX 59.38
+DI 64.70
-DI 2.03
Chandelier Exit (Long, 3 ATRs) 24.90
Chandelier Exit (Short, 3 ATRs) 16.30
Upper Bollinger Bands 24.23
Lower Bollinger Band 4.33
Percent B (%b) 1.26
BandWidth 139.34
MACD Line 3.36
MACD Signal Line 1.76
MACD Histogram 1.5952
Fundamentals Value
Market Cap 16.66 Million
Num Shares 56.5 Million
EPS -14.00
Price-to-Earnings (P/E) Ratio -2.11
Price-to-Sales 18.97
Price-to-Book 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.44
Resistance 3 (R3) 39.12 35.50 37.78
Resistance 2 (R2) 35.50 32.97 35.66 37.23
Resistance 1 (R1) 32.50 31.41 34.00 32.81 36.68
Pivot Point 28.87 28.87 29.62 29.03 28.87
Support 1 (S1) 25.88 26.34 27.38 26.19 22.32
Support 2 (S2) 22.25 24.78 22.41 21.77
Support 3 (S3) 19.25 22.25 21.22
Support 4 (S4) 19.56